The U.S. healthcare system is a $4 trillion labyrinth where inefficiency is the only thing more certain than death and taxes. In this chaos, Sagility Ltd has positioned itself not just as a service provider, but as a critical infrastructure layer. With its latest Q4 FY26 results, the company has delivered a masterclass in scaling within a high-barrier-to-entry niche, reporting a massive ₹ 20,243 million in quarterly revenue—a 29.1% year-on-year jump that has sent a clear signal to the market.
While the rest of the IT enabled services (ITES) sector often gets bogged down by generalist fatigue, Sagility is doubling down on its 100% U.S. healthcare focus. This isn’t just about processing claims; it’s about navigating the brutal “Medical Loss Ratio” (MLR) pressures that are currently squeezing the life out of American health insurers. When U.S. payers see their margins vanish, they don’t stop spending—they start looking for companies like Sagility to stop the bleeding.
1. At a Glance
Sagility is currently playing a high-stakes game in the U.S. healthcare outsourcing market, holding a 1.23% market share as of 2023. While that might sound small, in a multi-hundred-billion-dollar industry, it is a formidable foothold. The company serves 7 of the top 10 U.S. health insurers, creating a moat built on “relationship stickiness” that most competitors would kill for. Their top 5 client groups have an average tenure of 18 years. You don’t just “replace” a partner who has been handling your claims and clinical data since the early 2000s.
However, the numbers reveal a double-edged sword. Revenue concentration remains the elephant in the room. The top 3 clients contribute nearly 60% of total revenue. If one of these giants catches a cold—or worse, decides to bring operations back in-house—Sagility will feel the chills instantly. Furthermore, the voluntary attrition rate spiked to 38.1% in Q4 FY26. In a business where domain expertise is the primary product, losing nearly 4 out of every 10 employees annually is a red flag that screams operational stress or aggressive poaching.
Investors are currently staring at a Stock P/E of 21.2, which is actually at a discount compared to the industry median of 25.6. The company is effectively debt-free on a net basis, but it is lugging around ₹ 64,051 million in Goodwill on its balance sheet—a massive legacy of its carve-out and acquisitions. This is a “trust me” asset; if the business underperforms, those billions in intangible assets could turn into a write-off nightmare.
Is the 29.1% growth sustainable, or is this a one-time bump from the BroadPath acquisition?
2. Introduction
Sagility India Limited (formerly known as Berkmeer India) is a pure-play healthcare specialist. Unlike the massive Indian IT conglomerates that try to do everything for everyone, Sagility has a “Healthcare Only” mandate. This focus allows them to speak the language of Payers (the insurance companies like UnitedHealthcare and CVS Health) and Providers (hospitals like Johns Hopkins and the Cleveland Clinic).
The company was incorporated in 2021, but its DNA goes back over two decades. It essentially represents the carved-out healthcare business of Hinduja Global Solutions (HGS), now backed by EQT Private Capital Asia. This backing gives them the financial firepower to acquire companies like BroadPath, which they snapped up for ₹ 502 Crore in early 2025.
Operating from 31 delivery centers across five countries (India, Philippines, U.S., Jamaica, and Colombia), Sagility manages the “unsexy” but vital parts of healthcare: claims adjudication, payment integrity, and clinical management. In FY24 alone, they processed 105 million claims. Every claim is a transaction; every transaction is revenue.
3. Business Model – WTF Do They Even Do?
Sagility is the “plumbing” of the U.S. healthcare system. They operate primarily in two buckets:
The Payer Segment (88.5% of Revenue)
This is where the big money is. Sagility helps insurance companies manage the member lifecycle. From the
